Abstract
B cell chronic lymphocytic leukemia (CLL) lacks a consistent genetic abnormality. However, immunoglobulin VH gene segment mutation analysis has provided insights into the pathogenesis of these diseases and allowed the development of powerful prognostic markers. Immunoglobulin gene chromosomal translocations are rare in CLL and involve a distinct subset of genes including BCL3, BCL11A and CCND2. BCL2 translocations in CLL appear to arise via a different mechanism from comparable translocations seen in B cell non-Hodgkin lymphoma.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
Journal for ImmunoTherapy of Cancer Open Access 22 October 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P . Genomic aberrations and survival in chronic lymphocytic leukemia N Engl J Med 2000 343: 1910–1916
Devilee P, Cleton-Jansen A, Cornelisse CJ . Ever since Knudson Trends Genet 2001 17: 569–573
Corcoran MM, Rasool O, Liu Y, Iyengar A, Grander D, Ibbotson RE, Merup M, Wu X, Brodyansky V, Gardiner AC, Juliusson G, Chapman RM, Ivanova G, Tiller M, Gahrton G, Yankovsky N, Zabarovsky E, Oscier DG, Einhorn S . Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia Blood 1998 91: 1382–1390
Migliazza A, Bosch F, Komatsu H, Cayanis E, Martinotti S, Toniato E, Guccione E, Qu X, Chien M, Murty VV, Gaidano G, Inghirami G, Zhang P, Fischer S, Kalachikov SM, Russo J, Edelman I, Efstratiadis A, Dalla-Favera R . Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia Blood 2001 97: 2098–2104
Wolf S, Mertens D, Schaffner C, Korz C, Dohner H, Stilgenbauer S, Lichter P . B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions Hum Mol Genet 2001 10: 1275–1285
Jones PA, Laird PW . Cancer epigenetics comes of age Nat Genet 1999 21: 163–167
Lorincz MC, Groudine M . C(m)C(A/T)GG methylation: a new epigenetic mark in mammalian DNA? Proc Natl Acad Sci USA 2001 98: 10034–10036
Gardiner AC, Corcoran MM, Oscier DG . Cytogenetic, fluorescence in situ hybridisation, and clinical evaluation of translocations with concomitant deletion at 13q14 in chronic lymphocytic leukaemia Genes Chromos Cancer 1997 20: 73–81
Willis TG, Dyer MJS . The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies Blood 2000 96: 808–822
Kuppers R, Dalla-Favera R . Mechanisms of chromosomal translocations in B cell lymphomas Oncogene 2001 20: 5580–5594
Bergsagel PL, Kuehl WM . Chromosome translocations in multiple myeloma Oncogene 2001 20: 5611–5622
Hatzivassiliou G, Miller I, Takizawa J, Palanisamy N, Rao PH, Iida S, Tagawa S, Taniwaki M, Russo J, Neri A, Cattoretti G, Clynes R, Mendelsohn C, Chaganti RS, Dalla-Favera R . IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy Immunity 2001 14: 277–289
Shaughnessy J Jr, Gabrea A, Qi Y, Brents L, Zhan F, Tian E, Sawyer J, Barlogie B, Bergsagel PL, Kuehl M . Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma Blood 2001 98: 217–223
Sonoki T, Harder L, Horsman DE, Karran L, Taniguchi I, Willis TG, Gesk S, Steinemann D, Zucca E, Schlegelberger B, Sole F, Mungall AJ, Gascoyne RD, Siebert R, Dyer MJS . Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies Blood 2001 98: 2837–2844
Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, Schlegelberger B, Oscier DG, Siebert R, Tucker PW, Dyer MJS . The BCL11 gene family: involvement of BCL11A in lymphoid malignancies Blood 2001 98: 3413–3420
Welzel N, Le T, Marculescu R, Mitterbauer G, Chott A, Pott C, Kneba M, Du MQ, Kusec R, Drach J, Raderer M, Mannhalter C, Lechner K, Nadel B, Jaeger U . Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma Cancer Res 2001 61: 1629–1636
Muramatsu M, Honjo T . Complex layers of genetic alteration in the generation of antibody diversity Trends Immunol 2001 22: 66–68
http://www.nobel.se/medicine/laureates/1987/tonegawa-autobio.html
Lam KP, Kuhn R, Rajewsky K . In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death Cell 1997 90: 1073–1083
Ariizumi K, Wang Z, Tucker PW . Immunoglobulin heavy chain enhancer is located near or in an initiation zone of chromosomal DNA replication Proc Natl Acad Sci USA 1993 90: 3695–3699
Forrester WC, van Genderen C, Jenuwein T, Grosschedl R . Dependence of enhancer-mediated transcription of the immunoglobulin μ gene on nuclear matrix attachment regions Science 1994 265: 1221–1225
Zong RT, Das C, Tucker PW . Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukaemia nuclear bodies EMBO J 2000 19: 4123–4133
Betz AG, Milstein C, Gonzalez-Fernandez A, Pannell R, Larson T, Neuberger MS . Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region Cell 1994 77: 239–248
Skok JA, Brown KE, Azuara V, Caparros ML, Baxter J, Takacs K, Dillon N, Gray D, Perry RP, Merkenschlager M, Fisher AG . Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes Nat Immunol 2001 2: 848–854
Mundt CA, Nicholson IC, Zou X, Popov AV, Ayling C, Bruggemann M . Novel control motif cluster in the IgH delta-gamma 3 interval exhibits B cell-specific enhancer function in early development J Immunol 2001 166: 3315–3323
Dyer MJS, Heward JM, Zani VJ, Buccheri V, Catovsky D . Unusual deletions within the immunoglobulin heavy-chain locus in acute leukemias Blood 1993 82: 865–871
Maruyama M, Lam KP, Rajewsky K . Memory B-cell persistence is independent of persisting immunizing antigen Nature 2000 407: 636–642
Dahlenborg K, Pound JD, Gordon J, Borrebaeck CA, Carlsson R . Signals sustaining human immunoglobulin V gene hypermutation in isolated germinal centre B cells Immunology 2000 101: 210–217
Bergthorsdottir S, Gallagher A, Jainandunsing S, Cockayne D, Sutton J, Leanderson T, Gray D . Signals that initiate somatic hypermutation of B cells in vitro J Immunol 2001 166: 2228–2234
Liu YJ, Malisan F, de Bouteiller O, Guret C, Lebecque S, Banchereau J, Mills FC, Max EE, Martinez-Valdez H . Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation Immunity 1996 4: 241–250
Kinoshita K, Honjo T . Linking class-switch recombination with somatic hypermutation Nat Rev Mol Cell Biol 2001 2: 493–503
Goossens T, Klein U, Kuppers R . Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease Proc Natl Acad Sci USA 1998 95: 2463–2468
Jacobs H, Rajewsky K, Fukita Y, Bross L . Indirect and direct evidence for DNA double-strand breaks in hypermutating immunoglobulin genes Philos Trans R Soc Lond B Biol Sci 2001 356: 119–125
Rassenti LZ, Kipps TJ . Lack of allelic exclusion in B cell chronic lymphocytic leukemia J Exp Med 1997 185: 1435–1445
Rassenti LZ, Kipps TJ . Expression of Igβ (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion Blood 2000 95: 2725–2727
Mostoslavsky R, Kirillov A, Ji YH, Goldmit M, Holzmann M, Wirth T, Cedar H, Bergman Y . Demethylation and the establishment of kappa allelic exclusion Cold Spring Harb Symp Quant Biol 1999 64: 197–206
Klein U, Goossens T, Fischer M, Kanzier H, Braeuninger A, Rajewsky K, Kuppers R . Somatic hypermutation in normal and transformed human B cells Immunol Rev 1998 162: 261–280
Stevenson F, Sahota S, Zhu D, Ottensmeier C, Chapman C, Oscier D, Hamblin T . Insight into the origin and clonal history of B cell tumours as revealed by analysis of immunoglobulin variable region genes Immunol Rev 1998 162: 247–259
Hummel M, Stein H . Clinical relevance of immunoglobulin mutation analysis Curr Opin Oncol 2000 12: 395–402
Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerrra VP, Rai KR, Ferrarini M, Chiorazzi N . Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 1999 94: 1840–1847
Kuppers R, Gause A, Rajewsky K . B cells of chronic lymphatic leukemia express V genes in unmutated form Leukemia Res 1991 15: 487–496
Schroeder HW, Dighiero G . The pathogenesis of chronic lymphocytic leukemia; analysis of the antibody repertoire Immunol Today 1994 15: 288–294
Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia Blood 1999 94: 1848–1854
http://www.ncbi.nlm.nih.gov/PROW/guide/4279266g.htm
Thunberg U, Johnson A, Roos G, Thorn I, Tobin G, Sallstrom J, Sundstrom C, Rosenquist R . CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia Blood 2001 97: 1892–1893
Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, Oscier DG . CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia but CD38 expression may vary during the course of the disease Blood 2002 99: 1023–1029
Krober A, Seiler T, Benner A, Lichter P, Dohner H, Stilgenbauer S . IGVH mutation status, CD38 expression, genomic aberrations and survival in CLL B Cell Lymph Dis II 2001 54: (Abstr.)
Matrai Z, Lin K, Dennis M, Sherrington P, Zuzel M, Pettitt AR, Cawley JC . CD38 expression and IgVH gene mutation in B cell chronic lymphocytic leukemia Blood 2001 97: 1902–1903
Maloum K, Davi F, Merle-Beral H, Pritsch O, Magnac C, Vuillier F, Dighiero G, Troussard X, Mauro FF, Benichou J . Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia Blood 2000 96: 377–379
Widhopf GF, Marathe CM, Rassenti LZ, Byrd JC, Flinn IW, Gribben JG, Kipps TJ . Lack of correlation between immunoglobulin somatic mutation and expression of CD38 in chronic lymphocytic leukemia Blood 2000 96: 367a (Abstr.)
Jelinek DF, Hanson CA, Dwald GW, Witzig TE, Bone ND, Geyer SM, Tefferi A, Stenson MJ, Tschumper RC, Kay NE . Analysis of immunoglobulin (IG) variable (VH) region mutational status and CD38 phenotype for B-CLL patients entered on North Central cancer chemotherapy trials group (NCCTG) clinical trials Blood 2000 96: 835a (Abstr.)
Oscier DG, Gardiner A, Mould S, Glide S, Davis Z, Corcoran M, Ibbotson R, Orchard JA, Copplestone JA, Stevenson FK, Hamblin TJ . The mutational status of immunoglobulin V genes is the most important prognostic factor in B-CLL Blood 2000 96 (Suppl. 1): 366a
Pettitt AR, Sherrington PD, Stewart G, Cawley JC, Taylor AMR, Stankovic T . p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation Blood 2001 98: 814–822
Sherrington PD, Stankovic LK, Dennis M, Cawley JC, Pettitt AR . P53 dysfunction as a cause of the drug resistance and short survival of B-CLL patients with non-hypermutated IgVH genes Br J Haematol 2001 113 (Suppl. 1): 60
Cook GP, Tomlinson IM . The human immunoglobulin VH repertoire Immunol Today 1995 16: 237–242
Ferenc Livák F, Petrie HT . Somatic generation of antigen-receptor diversity: a reprise Trends Immunol 2001 22: 608–612
Dorner T, Foster SJ, Brezinschek HP, Lipsky PE . Analysis of the targeting of the hypermutational machinery and the impact of subsequent selection on the distribution of nucleotide changes in human VHDJH rearrangements Immunol Rev 1998 162: 161–171
Brezinschek HP, Brezinschek RI, Dorner T, Lipsky PE . Similar characteristics of the CDR3 of VH 1–69/DP-10 rearrangements in normal human peripheral blood and chronic lymphocytic leukaemia B cells Br J Haematol 1998 102: 516–521
Wang X, Stollar BD . Immunoglobulin VH gene expression in human aging Clin Immunol 1999 93: 132–142
Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, Schulman P, Vinciguerra VP, Rai K, Rassenti LZ, Kipps TJ, Dighiero G, Schroeder HW, Ferrarini M, Chiorazzi N . Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors J Clin Invest 1998 102: 1515–1525
Widhopf GF, Kipps TJ . Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells J Immunol 2001 166: 95–102
Chang B, Casali P . The CDR1 sequences of a major proportion of human germline IgVH genes are inherently susceptible to amino acid replacement Immunol Today 1994 15: 367–373
Lossos IS, Tibshirani R, Narasimhan B, Levy R . The inference of antigen selection on Ig genes J Immunol 2000 165: 5122–5126
Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE . Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia J Exp Med 2001 194: 1639–1647
Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, Neri A, Califano A, Dalla-Favera R . Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells J Exp Med 2001 194: 1625–1638
Fais F, Sellars B, Ghiotto F, Yan XJ, Dono M, Allen SL, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Schuster M, Vinciguerra VP, Rai K, Stevenson FK, Gregersen PK, Ferrarini M, Chiorazzi N . Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells J Clin Invest 1996 98: 1659–1666
Kayano H, Dyer MJS, Zani VJ, Laffan MA, Matutes E, Asou N, Katayama I, Catovsky D . Aberrant rearrangements within the immunoglobulin heavy chain locus in hairy cell leukemia Leuk Lymphoma 1994 14 (Suppl. 1): 41–47
Crossen PE, Morrison MJ . Aberrant rearrangements of the immunoglobulin heavy chain switch region in chronic B-cell leukemia Leuk Lymphoma 1998 31: 559–565
Laffan M, Luzzatto L . Anomalous rearrangements of the immunoglobulin heavy chain genes in human leukemias support the loop-out mechanism of class switch J Clin Invest 1992 90: 2299–2303
Sahota SS, Davis Z, Hamblin TJ, Stevenson FK . Somatic mutation of bcl-6 genes can occur in the absence of VH mutations in chronic lymphocytic leukemia Blood 2000 95: 3534–3540
Capello D, Fais F, Vivenza D, Migliaretti G, Chiorazzi N, Gaidano G, Ferrarini M . Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes Leukemia 2000 14: 811–815
Pasqualucci L, Neri A, Baldini L, Dalla-Favera R, Migliazza A . BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia Cancer Res 2000 60: 5644–5648
Storb U, Shen HM, Michael N, Kim N . Somatic hypermutation of immunoglobulin and non-immunoglobulin genes Philos Trans R Soc Lond B Biol Sci 2001 356: 13–19
Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R, Dalla-Favera R . Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas Nature 2001 412: 341–346
http://www.ncbi.nlm.nih.gov/PROW/guide/1936605662g.htm
Papavasiliou F, Misulovin Z, Suh H, Nussenzweig MC . The role of Ig beta in precursor B cell transition and allelic exclusion Science 1995 268: 408–411
Thompson AA, Do HN, Saxon A, Wall R . Widespread B29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia Leuk Lymphoma 1999 32: 561–569
Gordon MS, Kato RM, Lansigan F, Thompson AA, Wall R, Rawlings DJ . Aberrant B cell receptor signaling from B29 (Igγ, CD79b) gene mutations of chronic lymphocytic leukemia B cells Proc Natl Acad Sci USA 2000 97: 5504–5509
Alfarano A, Indraccolo S, Circosta P, Minuzzo S, Vallario A, Zamarchi R, Fregonese A, Calderazzo F, Faldella A, Aragno M, Camaschella C, Amadori A, Caligaris-Cappio F . An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia Blood 1999 93: 2327–2335
Rassenti LZ, Kipps TJ . Expression of Ig-beta (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion Blood 2000 95: 2725–2727
Malone CS, Miner MD, Doerr JR, Jackson JP, Jacobsen SE, Wall R, Teitell M . CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing Proc Natl Acad Sci USA 2001 98: 10404–10409
Bernard OA, Busson-LeConiat M, Ballerini P, Mauchauffe M, Della Valle V, Monni R, Nguyen Khac F, Mercher T, Penard-Lacronique V, Pasturaud P, Gressin L, Heilig R, Daniel MT, Lessard M, Berger R . A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia Leukemia 2001 15: 1495–1504
Matolcsy A, Casali P, Warnke RA, Knowles DM . Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene Blood 1996 88: 3937–3944
Huang DC, O'Reilly LA, Strasser A, Cory S . The anti-apoptosis function of BCL2 can be genetically separated from its inhibitory effect on cell cycle entry EMBO J 1997 16: 4628–4638
Willis TG, Jadayel DM, Coignet LJ, Abdul-Rauf M, Treleaven JG, Catovsky D, Dyer MJS . Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction Blood 1997 90: 2456–2464
Akasaka T, Akasaka H, Yonetani N, Ohno H, Yamabe H, Fukuhara S, Okuma M . Refinement of the BCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets Genes Chromos Cancer 1998 21: 17–29
Buchonnet G, Lenain P, Ruminy P, Lepretre S, Stamatoullas A, Parmentier F, Jardin F, Duval C, Tilly H, Bastard C . Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3′ BCL2 breakpoints and evidence of a new cluster Leukemia 2000 14: 1563–1569
Jager U, Bocskor S, Le T, Mitterbauer G, Bolz I, Chott A, Kneba M, Mannhalter C, Nadel B . Follicular lymphomas’ BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation Blood 2000 95: 3520–3529
Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC . Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia Blood 1993 82: 1820–1828
Adachi M, Cossman J, Longo D, Croce CM, Tsujimoto Y . Variant translocation of the bcl-2 gene to immunoglobulin lambda light chain gene in chronic lymphocytic leukemia Proc Natl Acad Sci USA 1989 86: 2771–2774
Adachi M, Tefferi A, Greipp PR, Kipps TJ, Tsujimoto Y . Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia J Exp Med 1990 171: 559–564
Dyer MJS, Zani VJ, Lu WZ, O'Byrne A, Mould S, Chapman R, Heward JM, Kayano H, Jadayel D, Matutes E, Catovsky D, Oscier DG . BCL2 translocations in leukemias of mature B cells Blood 1994 83: 3682–3688
Yabumoto K, Akasaka T, Muramatsu M, Kadowaki N, Hayashi T, Ohno H, Fukuhara S, Okuma M . Rearrangement of the 5′ cluster region of the BCL2 gene in lymphoid neoplasm: a summary of nine cases Leukemia 1996 10: 970–977
http://www.ncbi.nlm.nih.gov/entrez/viewer.cgi?val=NT010986.4
Adachi M, Tsujimoto Y . Potential Z-DNA elements surround the breakpoints of chromosome translocation within the 5′ flanking region of bcl-2 gene Oncogene 1990 5: 1653–1657
Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P, Korsmeyer SJ . Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma EMBO J 1988 7: 123–131
Gaidano G, Newcomb EW, Gong JZ, Tassi V, Neri A, Cortelezzi A, Calori R, Baldini L, Dalla-Favera R . Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia Am J Pathol 1994 144: 1312–1319
Youinou P, Jamin C, Lydyard PM . CD5 expression in human B-cell populations Immunol Today 1999 20: 312–316
Rimokh R, Gadoux M, Bertheas MF, Berger F, Garoscio M, Deleage G, Germain D, Magaud JP . FVT-1, a novel human transcription unit affected by variant translocation t(2;18)(p11;q21) of follicular lymphoma Blood 1993 81: 136–142
McKeithan TW, Rowley JD, Shows TB, Diaz MO . Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia Proc Natl Acad Sci USA 1987 84: 9257–9260
Michaux L, Dierlamm J, Wlodarska I, Bours V, Van den Berghe H, Hagemeijer A . t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases Cancer Genet Cytogenet 1997 94: 36–43
McKeithan TW, Takimoto GS, Ohno H, Bjorling VS, Morgan R, Hecht BK, Dube I, Sandberg AA, Rowley JD . BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study Genes Chromos Cancer 1997 20: 64–72
Wulczyn FG, Naumann M, Scheidereit C . Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB Nature 1992 358: 597–599
Rebollo A, Dumoutier L, Renauld JC, Zaballos A, Ayllon V, Martinez AC . Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors Mol Cell Biol 2000 20: 3407–3416
Westerheide SD, Mayo MW, Anest V, Hanson JL, Baldwin AS Jr . The putative oncoprotein bcl-3 induces cyclin D1 to stimulate G(1) transition Mol Cell Biol 2001 21: 8428–8436
Ong ST, Hackbarth ML, Degenstein LC, Baunoch DA, Anastasi J, McKeithan TW . Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice Oncogene 1998 16: 2333–2343
Richardson AL, Humphries CG, Tucker PW . Molecular cloning and characterization of the t(2;14) translocation associated with childhood chronic lymphocytic leukemia Oncogene 1992 7: 961–970
Li J, Shen H, Himmel KL, Dupuy AJ, Largaespada DA, Nakamura T, Shaughnessy JD Jr, Jenkins NA, Copeland NG . Leukaemia disease genes: large-scale cloning and pathway predictions Nat Genet 1999 23: 348–353
Nakamura T, Yamazaki Y, Saiki Y, Moriyama M, Largaespada DA, Jenkins NA, Copeland NG . Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product Mol Cell Biol 2000 20: 3178–3186
Saiki Y, Yamazaki Y, Yoshida M, Katoh O, Nakamura T . Human EVI9, a homologue of the mouse myeloid leukemia gene, is expressed in the hematopoietic progenitors and down-regulated during myeloid differentiation of HL60 cells Genomics 2000 70: 387–391
MartÃn-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B, Grote W, Novo FJ, Calasanz MJ, Hansmann ML, Dyer MJS, Siebert R . Recurrent involvement of the REL and BCL11A loci in classical Hodgkin's lymphoma Blood 2002 99: 1474–1477
Küppers R, Sonoki T, Satterwhite E, Gesk S, Harder L, Oscier DG, Tucker PW, Dyer MJS, Siebert R . Lack of somatic hypermutation of IGH genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene Leukemia 2002 (in press)
Qian L, Gong J, Liu J, Broome JD, Koduru PRK . Cyclin D2 promoter disrupted by t(12;22)(p13;q11.2) during transformation of chronic lymphocytic leukaemia to non- Hodgkin's lymphoma Br J Haematol 1999 106: 477–485
Solvason N, Wu WW, Parry D, Mahony D, Lam EW, Glassford J, Klaus GG, Sicinski P, Weinberg R, Liu YJ, Howard M, Lees E . Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development Int Immunol 2000 12: 631–638
Glassford J, Holman M, Banerji L, Clayton E, Klaus GG, Turner M, Lam EW . Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen receptor J Biol Chem 2001 276: 41040–41048
Bernal A, Pastore RD, Asgary Z, Keller SA, Cesarman E, Liou HC, Schattner EJ . Survival of leukemic B cells promoted by engagement of the antigen receptor Blood 2001 98: 3050–3057
Fenton JA, Vaandrager JW, Aarts WM, Bende RJ, Heering K, van Dijk M, Morgan G, van Noesel CJ, Schuuring E, Kluin PM . Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells Blood 2002 99: 716–718
Acknowledgements
We thank our colleagues in Bournemouth, Southampton, Sutton and Leicester for their help in the preparation of this manuscript. We thank Drs Reiner Siebert (Institute for Human Genetics, University of Kiel, Germany) for permission to quote unpublished data. We thank Dr Wal Zani (Amgen, UK) for his help in the preparation of Figure 2.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dyer, M., Oscier, D. The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia. Leukemia 16, 973–984 (2002). https://doi.org/10.1038/sj.leu.2402528
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402528
Keywords
This article is cited by
-
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
Journal for ImmunoTherapy of Cancer (2019)
-
A case of chronic lymphoblastic leukemia with an abnormal rare karyotype
Comparative Clinical Pathology (2015)
-
Prognostic factors in chronic lymphocytic leukemia—what do we need to know?
Nature Reviews Clinical Oncology (2011)
-
BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells
Leukemia (2008)
-
Analysis of VH gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic significance
Leukemia (2005)